The 10-day moving average for AQB crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AQB's RSI Indicator exited the oversold zone, 36 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +8.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where AQB advanced for three days, in 155 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Aroon Indicator entered an Uptrend today. In 64 of 85 cases where AQB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AQB as a result. In 82 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for AQB turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 38 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
AQB moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AQB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
AQB broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.793) is normal, around the industry mean (2.266). P/E Ratio (-0.214) is within average values for comparable stocks, (4.366). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). AQB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (2.089) is also within normal values, averaging (2.353).
The Tickeron PE Growth Rating for this company is 50 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. AQB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AQB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The RSI Oscillator for CHSCP moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 9 of the 24 cases the stock moved higher. This puts the odds of a move higher at 38%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for CHSCP just turned positive on November 04, 2026. Looking at past instances where CHSCP's MACD turned positive, the stock continued to rise in 8 of 54 cases over the following month. The odds of a continued upward trend are 15%.
Following a +0.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHSCP advanced for three days, in 58 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 18%.
CHSCP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHSCP as a result. In 26 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 25%.
CHSCP moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHSCP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 20%.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.266). P/E Ratio (0.000) is within average values for comparable stocks, (4.366). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). CHSCP has a moderately high Dividend Yield (0.078) as compared to the industry average of (0.038). P/S Ratio (0.000) is also within normal values, averaging (2.353).
The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 68 (best 1 - 100 worst), indicating slightly worse than average price growth. CHSCP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHSCP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
AQB | CHSCP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 63 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 56 | 68 | |
P/E GROWTH RATING 1..100 | 50 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 30 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CHSCP's Valuation (12) in the Agricultural Commodities Or Milling industry is somewhat better than the same rating for AQB (47) in the Biotechnology industry. This means that CHSCP’s stock grew somewhat faster than AQB’s over the last 12 months.
CHSCP's Profit vs Risk Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as AQB (100) in the Biotechnology industry. This means that CHSCP’s stock grew similarly to AQB’s over the last 12 months.
CHSCP's SMR Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as AQB (100) in the Biotechnology industry. This means that CHSCP’s stock grew similarly to AQB’s over the last 12 months.
AQB's Price Growth Rating (56) in the Biotechnology industry is in the same range as CHSCP (68) in the Agricultural Commodities Or Milling industry. This means that AQB’s stock grew similarly to CHSCP’s over the last 12 months.
AQB's P/E Growth Rating (50) in the Biotechnology industry is somewhat better than the same rating for CHSCP (100) in the Agricultural Commodities Or Milling industry. This means that AQB’s stock grew somewhat faster than CHSCP’s over the last 12 months.
| AQB | CHSCP | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 82% | 1 day ago 38% |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 26% |
| Momentum ODDS (%) | 1 day ago 85% | 1 day ago 25% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 15% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 19% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 18% |
| Advances ODDS (%) | 8 days ago 75% | 20 days ago 18% |
| Declines ODDS (%) | 6 days ago 88% | 1 day ago 20% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 34% |
| Aroon ODDS (%) | 1 day ago 75% | N/A |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AQB’s FA Score shows that 0 FA rating(s) are green while CHSCP’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AQB’s TA Score shows that 5 TA indicator(s) are bullish while CHSCP’s TA Score has 5 bullish TA indicator(s).
AQB (@Agricultural Commodities/Milling) experienced а -20.00% price change this week, while CHSCP (@Agricultural Commodities/Milling) price change was -0.45% for the same time period.
The average weekly price growth across all stocks in the @Agricultural Commodities/Milling industry was -0.32%. For the same industry, the average monthly price growth was -7.36%, and the average quarterly price growth was -13.23%.
The Agricultural Commodities/Milling industry includes companies that are involved in farming activities, such as crop production, livestock management and animal feed, for commercial purposes. The industry includes a wide range of operations from growing corn, to grain and oilseed processing to the operation of flour mills. Changes in consumer tastes is one of the critical factors influencing what products are grown and raised in this industry. Potential risks to the business include climate change and fluctuations in global prices of agricultural products. Archer-Daniels-Midland Company, Elanco Animal Health, Inc., Bunge Limited and Canopy Growth Corporation are some of the biggest U.S. companies operating in this industry.
A.I.dvisor tells us that AQB and EDBL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AQB and EDBL's prices will move in lockstep.
| Ticker / NAME | Correlation To AQB | 1D Price Change % | ||
|---|---|---|---|---|
| AQB | 100% | -1.85% | ||
| EDBL - AQB | 21% Poorly correlated | -1.02% | ||
| ALCO - AQB | 20% Poorly correlated | +1.67% | ||
| LMNR - AQB | 20% Poorly correlated | +2.26% | ||
| VFF - AQB | 10% Poorly correlated | -1.39% | ||
| CHSCP - AQB | 9% Poorly correlated | -0.21% | ||
More | ||||